Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Antifibrotic Agents
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Antifibrotic Agents
Tree Number(s)
D27.505.954.158.273
Unique ID
D000088962
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000088962
Scope Note
These agents are used to reduce
FIBROSIS
affecting organs and formation of scar
TISSUES
such as in SCLERODERMA patients.
Entry Term(s)
Anti-Fibrotic Agents
Public MeSH Note
2022
History Note
2022
Date Established
2022/01/01
Date of Entry
2021/07/09
Revision Date
2021/07/01
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
analysis (AN)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Inflammatory Agents [D27.505.954.158]
Anti-Inflammatory Agents, Non-Steroidal [D27.505.954.158.030]
Antifibrotic Agents [D27.505.954.158.273]
Demulcents [D27.505.954.158.515]
Mast Cell Stabilizers [D27.505.954.158.636]
Tumor Necrosis Factor Inhibitors [D27.505.954.158.757]
Expand All
Collapse All
Antifibrotic Agents
Preferred
Concept UI
M000742645
Scope Note
These agents are used to reduce
FIBROSIS
affecting organs and formation of scar
TISSUES
such as in SCLERODERMA patients.
Terms
Antifibrotic Agents
Preferred Term
Term UI
T001104551
Date
04/13/2021
LexicalTag
NON
ThesaurusID
NLM (2022)
Anti-Fibrotic Agents
Term UI
T001104552
Date
04/13/2021
LexicalTag
NON
ThesaurusID
NLM (2022)
page delivered in 0.126s